186 related articles for article (PubMed ID: 14517214)
1. Restoration of C/EBPalpha expression in a BCR-ABL+ cell line induces terminal granulocytic differentiation.
Tavor S; Park DJ; Gery S; Vuong PT; Gombart AF; Koeffler HP
J Biol Chem; 2003 Dec; 278(52):52651-9. PubMed ID: 14517214
[TBL] [Abstract][Full Text] [Related]
2. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.
Perrotti D; Cesi V; Trotta R; Guerzoni C; Santilli G; Campbell K; Iervolino A; Condorelli F; Gambacorti-Passerini C; Caligiuri MA; Calabretta B
Nat Genet; 2002 Jan; 30(1):48-58. PubMed ID: 11753385
[TBL] [Abstract][Full Text] [Related]
3. Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPalpha.
Ferrari-Amorotti G; Keeshan K; Zattoni M; Guerzoni C; Iotti G; Cattelani S; Donato NJ; Calabretta B
Blood; 2006 Aug; 108(4):1353-62. PubMed ID: 16670262
[TBL] [Abstract][Full Text] [Related]
4. C/EBPdelta expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation.
Gery S; Tanosaki S; Hofmann WK; Koppel A; Koeffler HP
Oncogene; 2005 Feb; 24(9):1589-97. PubMed ID: 15674331
[TBL] [Abstract][Full Text] [Related]
5. The effects of Bcr-Abl on C/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate.
Schuster C; Forster K; Dierks H; Elsasser A; Behre G; Simon N; Danhauser-Riedl S; Hallek M; Warmuth M
Blood; 2003 Jan; 101(2):655-63. PubMed ID: 12393654
[TBL] [Abstract][Full Text] [Related]
6. Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancy.
Wagner K; Zhang P; Rosenbauer F; Drescher B; Kobayashi S; Radomska HS; Kutok JL; Gilliland DG; Krauter J; Tenen DG
Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6338-43. PubMed ID: 16606850
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBPalpha in p210BCR/ABL-expressing cells.
Soliera AR; Lidonnici MR; Ferrari-Amorotti G; Prisco M; Zhang Y; Martinez RV; Donato NJ; Calabretta B
Blood; 2008 Sep; 112(5):1942-50. PubMed ID: 18550858
[TBL] [Abstract][Full Text] [Related]
8. High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation.
Chang JS; Santhanam R; Trotta R; Neviani P; Eiring AM; Briercheck E; Ronchetti M; Roy DC; Calabretta B; Caligiuri MA; Perrotti D
Blood; 2007 Aug; 110(3):994-1003. PubMed ID: 17475908
[TBL] [Abstract][Full Text] [Related]
9. Signal transducers and activators of transcription 3 augments the transcriptional activity of CCAAT/enhancer-binding protein alpha in granulocyte colony-stimulating factor signaling pathway.
Numata A; Shimoda K; Kamezaki K; Haro T; Kakumitsu H; Shide K; Kato K; Miyamoto T; Yamashita Y; Oshima Y; Nakajima H; Iwama A; Aoki K; Takase K; Gondo H; Mano H; Harada M
J Biol Chem; 2005 Apr; 280(13):12621-9. PubMed ID: 15664994
[TBL] [Abstract][Full Text] [Related]
10. hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis.
Iervolino A; Santilli G; Trotta R; Guerzoni C; Cesi V; Bergamaschi A; Gambacorti-Passerini C; Calabretta B; Perrotti D
Mol Cell Biol; 2002 Apr; 22(7):2255-66. PubMed ID: 11884611
[TBL] [Abstract][Full Text] [Related]
11. Expression of the transcriptional repressor Gfi-1 is regulated by C/EBP{alpha} and is involved in its proliferation and colony formation-inhibitory effects in p210BCR/ABL-expressing cells.
Lidonnici MR; Audia A; Soliera AR; Prisco M; Ferrari-Amorotti G; Waldron T; Donato N; Zhang Y; Martinez RV; Holyoake TL; Calabretta B
Cancer Res; 2010 Oct; 70(20):7949-59. PubMed ID: 20924107
[TBL] [Abstract][Full Text] [Related]
12. Gadd45a deficiency accelerates BCR-ABL driven chronic myelogenous leukemia.
Mukherjee K; Sha X; Magimaidas A; Maifrede S; Skorski T; Bhatia R; Hoffman B; Liebermann DA
Oncotarget; 2017 Feb; 8(7):10809-10821. PubMed ID: 28086219
[TBL] [Abstract][Full Text] [Related]
13. Vitamin Е activates expression of С/EBP alpha transcription factor and G-CSF receptor in leukemic K562 cells.
Shvachko LP; Zavelevich MP; Gluzman DF; Kravchuk IV; Telegeev GD
Exp Oncol; 2018 Dec; 40(4):328-331. PubMed ID: 30593760
[TBL] [Abstract][Full Text] [Related]
14. Induction of C/EBPalpha activity alters gene expression and differentiation of human CD34+ cells.
Cammenga J; Mulloy JC; Berguido FJ; MacGrogan D; Viale A; Nimer SD
Blood; 2003 Mar; 101(6):2206-14. PubMed ID: 12406909
[TBL] [Abstract][Full Text] [Related]
15. BCR-ABL promotes neutrophil differentiation in the chronic phase of chronic myeloid leukemia by downregulating c-Jun expression.
Kobayashi S; Kimura F; Ikeda T; Osawa Y; Torikai H; Kobayashi A; Sato K; Motoyoshi K
Leukemia; 2009 Sep; 23(9):1622-7. PubMed ID: 19357699
[TBL] [Abstract][Full Text] [Related]
16. Multipotent hematopoietic cell lines derived from C/EBPalpha(-/-) knockout mice display granulocyte macrophage-colony-stimulating factor, granulocyte- colony-stimulating factor, and retinoic acid-induced granulocytic differentiation.
Collins SJ; Ulmer J; Purton LE; Darlington G
Blood; 2001 Oct; 98(8):2382-8. PubMed ID: 11588034
[TBL] [Abstract][Full Text] [Related]
17. Hes1 promotes blast crisis in chronic myelogenous leukemia through MMP-9 upregulation in leukemic cells.
Nakahara F; Kitaura J; Uchida T; Nishida C; Togami K; Inoue D; Matsukawa T; Kagiyama Y; Enomoto Y; Kawabata KC; Chen-Yi L; Komeno Y; Izawa K; Oki T; Nagae G; Harada Y; Harada H; Otsu M; Aburatani H; Heissig B; Hattori K; Kitamura T
Blood; 2014 Jun; 123(25):3932-42. PubMed ID: 24825862
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL.
Horita M; Andreu EJ; Benito A; Arbona C; Sanz C; Benet I; Prosper F; Fernandez-Luna JL
J Exp Med; 2000 Mar; 191(6):977-84. PubMed ID: 10727459
[TBL] [Abstract][Full Text] [Related]
19. C/EBPβ promotes BCR-ABL-mediated myeloid expansion and leukemic stem cell exhaustion.
Hayashi Y; Hirai H; Kamio N; Yao H; Yoshioka S; Miura Y; Ashihara E; Fujiyama Y; Tenen DG; Maekawa T
Leukemia; 2013 Mar; 27(3):619-28. PubMed ID: 22948537
[TBL] [Abstract][Full Text] [Related]
20. Elevated PIN1 expression by C/EBPalpha-p30 blocks C/EBPalpha-induced granulocytic differentiation through c-Jun in AML.
Pulikkan JA; Dengler V; Peer Zada AA; Kawasaki A; Geletu M; Pasalic Z; Bohlander SK; Ryo A; Tenen DG; Behre G
Leukemia; 2010 May; 24(5):914-23. PubMed ID: 20376080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]